Louke Delrue

Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial

Piet Ost, Dries Reynders, Karel Decaestecker et al. · Journal of Clinical Oncology · 2017 · 1.3K citations

Mdt Arm, Urology, Surgical Oncology +12

Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence

Karel Decaestecker, Gert De Meerleer, Bieke Lambert et al. · Radiation Oncology · 2014 · 254 citations · Full text

Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials

Matthew P. Deek, Kim Van der Eecken, Philip Sutera et al. · Journal of Clinical Oncology · 2022 · 222 citations · Full text

Salvage Stereotactic Body Radiotherapy for Patients With Limited Prostate Cancer Metastases: Deferring Androgen Deprivation Therapy

Patrick Berkovic, Gert De Meerleer, Louke Delrue et al. · Clinical Genitourinary Cancer · 2012 · 189 citations

Urology, Surgical Oncology, Radiation Therapy +6

Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence (STOMP): Five-year results of a randomized phase II trial.

Piet Ost, Dries Reynders, Karel Decaestecker et al. · Journal of Clinical Oncology · 2020 · 148 citations

Cancer Management, Five-year Results, Oncology +16